Evofem

-$0.0401 (-4.66%) As of 6:49 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Evofem and other ETFs, options, and stocks.

About EVFM

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate) a hormone-free vaginal gel and EVO100 an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women.

CEO
Saundra L. Pelletier
Employees
147
Headquarters
San Diego, California
Founded
2007

EVFM Key Statistics

Market Cap
143.82M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.64M
High Today
$0.8699
Low Today
$0.8029
Open Price
$0.86
Volume
4.69M
52 Week High
$5.53
52 Week Low
$0.751

EVFM Earnings

-$0.56
-$0.37
-$0.19
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure